Events in 2024

This one-hour focused webinar will include the following subject matter:
• Brief discussion of the types of cytology cell blocks often requiring ICC demonstration
• Discussion of how cell block preparation influences optimal ICC staining performance
• Discussion of how to avoid or troubleshoot the most common ICC staining problems in cell blocks
• An outline of potential for false positive and negative results and regulatory compliance if performing ICC with companion diagnostics
• An outline of validation required and quality measures suitable for monitoring performance

This webinar provides an in-depth focus on the recognition and prevention of technical issues that occur in ICC, and guidance on ways to ensure ICC quality in diagnostic Cellular Pathology.

This webinar and associated microscope workshop, introduces the four basic tissue types: epithelial tissue, connective tissue, muscle tissue, and nervous tissue, and provides basic knowledge and competence in the microscopic recognition of normal histological tissue and some key aspects of pathological tissue. Utilises presentations, hands on and discussion-based sessions.

This focussed webinar discusses the importance of constant review of data collected during audit and day-to-day work activities, to look for trends and subsequently ensure continuous improvement.

This webinar provides a focus on the more advanced ICC/ISH applications currently being utilised in diagnostic Cellular Pathology. Delegates will acquire the knowledge on the use of routine diagnostic ICC and drug aligned companion diagnostic assays used Utilises presentations, and discussion-based sessions.

This webinar will discuss how a ROSE service can be set up to be of value to reporting Pathologists, Clinicians and, most importantly, the patient.

This webinar will cover the most commonly used methods available for preparation of cell blocks from cytology samples.

Explaining why tumours are not simply the proliferation of one type of “malignant cell” but a more complex matrix of tumour cell clones, also looking at what implications clonality has on tumour recurrence and metastatic spread.

A look at how patients are now able to have their tumour tissue profiled by molecular analysis and identify the gene expression profile unique to their cancer.